Cliff Asness's ZVRA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 79,915 shares of Zevra Therapeutics, Inc. (ZVRA) worth $744,807, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ZVRA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 152,311 shares. Largest reduction occurred in Q3 2022, reducing 107,341 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Zevra Therapeutics (ZVRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zevra Therapeutics (ZVRA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -101,214 | Reduce 55.88% | 79,915 | $9.32 |
| Q4 2025 | +28,818 | Add 18.92% | 181,129 | $8.96 |
| Q3 2025 | +152,311 | New Buy | 152,311 | $9.51 |
| Q1 2025 | -11,728 | Sold Out | 0 | $0.00 |
| Q4 2024 | +11,728 | New Buy | 11,728 | $8.34 |
| Q3 2022 | -107,341 | Sold Out | 0 | $0.00 |
| Q2 2022 | -102,759 | Reduce 48.91% | 107,341 | $4.46 |
| Q1 2022 | +149,668 | Add 247.66% | 210,100 | $5.03 |
| Q4 2021 | -40,378 | Reduce 40.05% | 60,432 | $8.70 |
| Q3 2021 | +100,810 | New Buy | 100,810 | $9.33 |
Cliff Asness's Zevra Therapeutics Investment FAQs
Cliff Asness first purchased Zevra Therapeutics, Inc. (ZVRA) in Q3 2021, acquiring 100,810 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Zevra Therapeutics, Inc. (ZVRA) for 10 quarters since Q3 2021.
Cliff Asness's largest addition to Zevra Therapeutics, Inc. (ZVRA) was in Q3 2025, adding 152,311 shares worth $1.45 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 79,915 shares of Zevra Therapeutics, Inc. (ZVRA), valued at approximately $744,807.
As of the Q1 2026 filing, Zevra Therapeutics, Inc. (ZVRA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Zevra Therapeutics, Inc. (ZVRA) was 210,100 shares, as reported at the end of Q1 2022.